Here are a few highlights of cancer research news that have recently caught my attention:

• Recently two large studies were published linking low vitamin D levels to cancer and other diseases. The first study demonstrates that vitamin D is critically important in physiological processes while also indicating regulation of a very large number of genes either directly or indirectly responsive to vitamin D receptors. In the second study, scientists found evidence that vitamin D protects against numerous illnesses. Both papers were published in the British Medical Journal.
• Scientists in the UK have identified a gene mutation that may be responsible for cases of melanoma.  The report was published in Nature Genetics.
• A study led by researchers at St. Jude Children’s Research Hospital revealed promising results for treatment of childhood brain tumors using adult cancer drugs. The results were published in the journal Cancer Cell.

Please feel free to contact Marisol Hernandez for comments on the latest cancer research news.

Here are a few highlights of cancer research news that have recently caught my attention:

• Researchers at allied cancer institutes have found that patients with melanoma receiving the drug nivolumab had longer periods of remission.  The complete study is published in the Journal of Clinical Oncology.
• Anti-psychotic drugs offer new hopes for patients with glioblastoma according to a study by researchers at the University of California, San Diego.
• Researchers at the Dana Farber Institute have found an “exceptional” response from targeted drugs while treating a patient with advanced bladder cancer.  The study is published in the journal Cancer Discovery.

Please feel free to contact Marisol Hernandez for comments on the latest cancer research news.

Here are a few highlights of cancer research news that have recently caught my attention:

• Study at the University of Arizona Cancer Center at St. Joseph’s Hospital and Medical Center reveals that women with advanced cervical cancer treated with the combined use of bevacizumab (Avastin®) and chemotherapy are living four months longer than those being treated with chemotherapy alone.  Research is published in the New Journal of Medicine.
• Researchers at the University of Toronto found higher success rates of drugs that target cells with a biomarker than small-molecule drugs that didn’t focus on a target. The 14 year study published in the February issue of the Journal of Thoracic Oncology focused on drugs used for treating patients with advanced non-small cell lung cancer (NSCLC).
• A new study reveals that having a diet rich in animal protein places you at a greater risk of dying from cancer than those individuals with a low protein diet.  Results from a nearly two decade study have been published in latest issue of Cell Metabolism.

Please feel free to contact Marisol Hernandez for comments on the latest cancer research news.